diabetes

Submitted by moderatorj on Tue, 10/09/2012 - 23:15

Diabetes: Medtronic sues Insulet over OmniPod device

Diabetes: Medtronic sues Insulet over OmniPod device

Mass Device

Novo Nordisk Is Positioned To Profit Off Of Obesity Epidemic But Price May Be Rich

Novo Nordisk Is Positioned To Profit Off Of Obesity Epidemic But Price May Be Rich

Seeking Alpha

Lilly Backs Broad Diabetes Range to Challenge Rivals

Lilly Backs Broad Diabetes Range to Challenge Rivals

Bloomberg

Submitted by moderatorj on Sat, 10/06/2012 - 22:40

Much-hyped renal denervation devices could help diabetics, too

Much-hyped renal denervation devices could help diabetics, too

FierceMedicalDevice

New Diabetes Drug Can Bolster J&J’s $74 Value

New Diabetes Drug Can Bolster J&J’s $74 Value

Trefis

Pharma’s Diabetes War Escalates

Pharma’s Diabetes War Escalates

Motley Fool

Extending the Diabetes Dominance

Extending the Diabetes Dominance

Motley Fool

Novo to Hire 1,000 People in 2 Years in Emerging Markets

Novo to Hire 1,000 People in 2 Years in Emerging Markets

Bloomberg Businessweek

Novo Says It’s Likely to Benefit From Bristol-Amylin Tie-Up

Novo Says It’s Likely to Benefit From Bristol-Amylin Tie-Up

Bloomberg

Big Pharma to benefit from growth in diabetes: S&P

Big Pharma to benefit from growth in diabetes: S&P

Marketwatch